AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …

The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The most common side …

Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

Dec 2, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia.

About AUSTEDO XR Extended-Release Tablets and AUSTEDO Tablets AUSTEDO XR and AUSTEDO are the first vesicular monoamine transporter 2 (VMAT2) inhibitors approved by the U.S. Food and …

Oct 25, 2025 · Treatment Options for Tardive Dyskinesia The most effective treatments for tardive dyskinesia are the FDA-approved VMAT2 inhibitors valbenazine and deutetrabenazine, which should …

Austedo is a brand of deutetrabenazine. This medication treats involuntary movements caused by tardive dyskinesia or Huntington's disease.

1 day ago · Tardive dyskinesia is a movement disorder caused most often by long-term use of certain medicines that block dopamine. If you have tardive dyskinesia , you will notice repeated, involuntary …

Nov 12, 2024 · It demonstrates real-world treatment patterns and outcomes with once-daily Austedo XR (deutetrabenazine) extended-release tablets and twice-daily Austedo (deutetrabenazine) tablets, …

Reduce involuntary movements with AUSTEDO XR® (deutetrabenazine) tablets treatment for TD. See safety info and boxed warning.